Cleared Traditional

K241810 - MICROLET®NEXT Lancet (FDA 510(k) Clearance)

Aug 2024
Decision
55d
Days
Class 2
Risk

K241810 is an FDA 510(k) clearance for the MICROLET®NEXT Lancet. This device is classified as a Single Use Only Blood Lancet Without An Integral Sharps Injury Prevention Feature (Class II - Special Controls, product code QRK).

Submitted by Ascensia Diabetes Care U.S., Inc. (Parsippany, US). The FDA issued a Cleared decision on August 15, 2024, 55 days after receiving the submission on June 21, 2024.

This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 878.4850. A Disposable Blood Lancet Intended For A Single Use That Is Comprised Of A Single Use Blade Attached To A Solid, Nonreusable Base That Is Used To Puncture The Skin To Obtain A Drop Of Blood For Diagnostic Purposes..

Submission Details

510(k) Number K241810 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 21, 2024
Decision Date August 15, 2024
Days to Decision 55 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code QRK - Single Use Only Blood Lancet Without An Integral Sharps Injury Prevention Feature
Device Class Class II - Special Controls
CFR Regulation 21 CFR 878.4850
Definition A Disposable Blood Lancet Intended For A Single Use That Is Comprised Of A Single Use Blade Attached To A Solid, Nonreusable Base That Is Used To Puncture The Skin To Obtain A Drop Of Blood For Diagnostic Purposes.